Systematic Review of Modelling Approaches for the Cost Effectiveness of Hepatitis C Treatment with Direct-Acting Antivirals

被引：0
|
作者：
Jagpreet Chhatwal
Tianhua He
Maria A. Lopez-Olivo
机构：
[1] Harvard Medical School,Institute for Technology Assessment, Massachusetts General Hospital
[2] Tsinghua University School of Medicine,Department of General Internal Medicine
[3] The University of Texas,undefined
[4] MD Anderson Cancer Center,undefined
来源：
PharmacoEconomics | 2016年 / 34卷
关键词：
Sustained Virological Response Rate; Telaprevir; Sofosbuvir; Boceprevir; Consolidate Health Economic Evaluation Reporting Standard;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：551 / 567
页数：16
相关论文
共 50 条
  • [31] Update on hepatitis C: Direct-acting antivirals
    Seifert, Leon L.
    Perumpail, Ryan B.
    Ahmed, Aijaz
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (28) : 2829 - 2833
  • [32] Direct-acting antivirals: the endgame for hepatitis C?
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Colombo, Massimo
    Aghemo, Alessio
    CURRENT OPINION IN VIROLOGY, 2017, 24 : 31 - 37
  • [33] COST-EFFECTIVENESS AND MODELING APPROACHES OF DIRECT-ACTING ANTIVIRAL AGENTS IN CHRONIC HEPATITIS C INFECTION: A SYSTEMATIC LITERATURE REVIEW
    Szilberhorn, L.
    Agh, T.
    Fasseeh, A. N.
    Kalo, Z.
    VALUE IN HEALTH, 2017, 20 (09) : A411 - A411
  • [34] Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals
    Samur, Sumeyye
    Kues, Brian
    Ayer, Turgay
    Roberts, Mark S.
    Kanwal, Fasiha
    Hur, Chin
    Donnell, Drew Michael S.
    Chung, Raymond T.
    Chhatwal, Jagpreet
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (01) : 115 - +
  • [35] Effectiveness of chronic hepatitis C treatment with direct-acting antivirals in the Public Health System in Brazil
    Holzmann, Iandra
    Tovo, Cristiane V.
    Minme, Roseline
    Leal, Monica P.
    Kliemann, Michele L.
    Ubirajara, Camila
    Aquino, Amanda A.
    Araujo, Bruna
    Almeida, Paulo R. L.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2018, 22 (04): : 317 - 322
  • [36] Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C
    Chen, Pingyu
    Jin, Min
    Cao, Yang
    Li, Hongchao
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2021, 19 (03) : 371 - 387
  • [37] Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis
    Ciaccio, Antonio
    Cortesi, Paolo A.
    Bellelli, Giuseppe
    Rota, Matteo
    Conti, Sara
    Okolicsanyi, Stefano
    Rota, Monica
    Cesana, Giancarlo
    Mantovani, Lorenzo G.
    Annoni, Giorgio
    Strazzabosco, Mario
    LIVER INTERNATIONAL, 2017, 37 (07) : 982 - 994
  • [38] Cost-Effectiveness Analysis of Oral Direct-Acting Antivirals for Chinese Patients with Chronic Hepatitis C
    Pingyu Chen
    Min Jin
    Yang Cao
    Hongchao Li
    Applied Health Economics and Health Policy, 2021, 19 : 371 - 387
  • [39] Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
    Jimenez-Perez, Miguel
    Gonzalez-Grande, Rocio
    Espana Contreras, Pilar
    Pinazo Martinez, Isabel
    de la Cruz Lombardo, Jesus
    Olmedo Martin, Raul
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (29) : 6573 - 6581
  • [40] New direct-acting antivirals' combination for the treatment of chronic hepatitis C
    Asselah, Tarik
    Marcellin, Patrick
    LIVER INTERNATIONAL, 2011, 31 : 68 - 77
12345